Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2025-12-26 @ 2:22 PM
Study NCT ID:
NCT02347657
Status:
COMPLETED
Last Update Posted:
2018-06-12
First Post:
2015-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-12
First Submit QC Date:
None
Study First Post Date:
2015-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-14
Results First Submit QC Date:
None
Results First Post Date:
2018-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-02-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-05-08
Last Update Post Date:
2018-06-12
Last Update Post Date Type:
ACTUAL